Uppsala, Sweden

Per Dahlberg

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: General Electric Company. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Per Dahlberg

Introduction

Per Dahlberg is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of radiopharmaceuticals, particularly in the manufacturing of radioisotopes. His work is characterized by a focus on enhancing the efficiency and safety of radiopharmaceutical preparation.

Latest Patents

Dahlberg holds a patent for "Systems, methods and apparatus for manufacturing radioisotopes." This innovative patent describes a standalone radiopharmaceutical preparation hotcell designed for preparing radiopharmaceuticals. The hotcell includes a housing with multiple compartments, including a pharmaceutical synthesizing and dispensing compartment, which is maintained at a first pressure, and a second compartment at a different pressure. This design utilizes a compartment pressurization system to ensure optimal conditions for radiopharmaceutical production.

Career Highlights

Per Dahlberg is associated with General Electric Company, where he has been instrumental in advancing technologies related to radiopharmaceuticals. His expertise in this niche area has positioned him as a key figure in the development of innovative solutions for medical applications.

Collaborations

Dahlberg has worked alongside talented colleagues such as Magnus Wallen and Tomas Eriksson. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Per Dahlberg's contributions to the field of radiopharmaceuticals through his innovative patent and collaborative work at General Electric Company highlight his importance as an inventor. His advancements in manufacturing radioisotopes continue to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…